Hisamitsu Pharmaceutical’s ¥457 billion plan to go private is being seen as a prime example of a flight from public markets among Japan’s drugmakers, with analysts expecting more to follow. https://www.japantimes.co.jp/business/2026/01/08/companies/buyout-wave-seen-among-japanese-drugmakers/?utm_medium=Social&utm_source=mastodon #business #companies #hisamitsu #salonpas #pharmaceuticals #acquisitions #stocks #tse #pharmaceuticals #health #medicine

Hisamitsu Pharmaceutical surged the most in more than 47 years after the Japanese maker of pain-relief patches announced it would go private in a management buyout valued at about $2.9 billion. https://www.japantimes.co.jp/business/2026/01/07/markets/hisamitsu-shares-jump-buyout/?utm_medium=Social&utm_source=mastodon #business #markets #hisamitsu #salonpas #pharmaceuticals #acquisitions

日本久光製藥推出《手掌多汗症》廣告影片 用海獺布偶拍攝超可愛成功引起網友關注
15:50

大家覺得自己是那種容易流手汗的人嗎？有些人會因為天氣太熱流手汗，有些人會因為緊張、焦慮流手汗，但有些人則是因為「手掌多汗症」而流手汗，而後者的情況會稍微嚴重一點，像是寫字等場合，是需要墊手帕或衛生紙才...
https://news.gamme.com.tw/1768791
#廣告 #海獺 #多汗症 #久光製藥 #Hisamitsu